Market Research Life Sciences Market Research Medical Devices Market Research Manufacturing & Packaging Market Research

Left Atrial Appendage Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Best Price Guarantee Length Publisher Published Date SKU
from $2,500 56 Pages GlobalData March, 2024 GBDT18743636
Best Price Guarantee
Price from $2,500
Length 56 Pages
Publisher GlobalData
Published Date March, 2024
SKU GBDT18743636

Left Atrial Appendage Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Left Atrial Appendage Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Left Atrial Appendage Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Left Atrial Appendage Closure Device prevents blood flow into the left atrial appendage, preventing blood clotting or pooling.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Left Atrial Appendage Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Left Atrial Appendage Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Left Atrial Appendage Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Left Atrial Appendage Closure Devices Overview
4 Products under Development
4.1 Left Atrial Appendage Closure Devices - Pipeline Products by Stage of Development
4.2 Left Atrial Appendage Closure Devices - Pipeline Products by Territory
4.3 Left Atrial Appendage Closure Devices - Pipeline Products by Regulatory Path
4.4 Left Atrial Appendage Closure Devices - Pipeline Products by Estimated Approval Date
4.5 Left Atrial Appendage Closure Devices - Ongoing Clinical Trials
5 Left Atrial Appendage Closure Devices - Pipeline Products under Development by Companies
5.1 Left Atrial Appendage Closure Devices Companies - Pipeline Products by Stage of Development
5.2 Left Atrial Appendage Closure Devices – Companies Pipeline Products by Stage of Development
6 Left Atrial Appendage Closure Devices Companies and Product Overview
6.1 Abbott Medical Company Overview
6.1.1 Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview
6.2 Aegis Medical Innovations Inc. Company Overview
6.2.1 Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.3 Append Medical Company Overview
6.3.1 Append Medical Pipeline Products & Ongoing Clinical Trials Overview
6.4 AuriGen Medical Ltd Company Overview
6.4.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.5 Boston Scientific Corp Company Overview
6.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
6.6 Conformal Medical Inc Company Overview
6.6.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 Cor Habere Corp Company Overview
6.7.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
6.8 Hangzhou Denuo Electrophysiology Medical Technology Co Ltd Company Overview
6.8.1 Hangzhou Denuo Electrophysiology Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.9 Hansen Medical Inc (Inactive) Company Overview
6.9.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.1 Jenscare Scientific Co Ltd Company Overview
6.10.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.11 Johnson & Johnson Company Overview
6.11.1 Johnson & Johnson Pipeline Products & Ongoing Clinical Trials Overview
6.12 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
6.12.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.13 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
6.13.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.14 LuSeed Vascular Company Overview
6.14.1 LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview
6.15 Mayo Clinic Company Overview
6.15.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
6.16 Medtronic Plc Company Overview
6.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
6.17 Northwestern University Company Overview
6.17.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
6.18 SentreHEART Inc Company Overview
6.18.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
6.19 Shanghai Shenqi Medical Technology Co Ltd Company Overview
6.19.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.2 The Chaim Sheba Medical Center Company Overview
6.20.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
7 Left Atrial Appendage Closure Devices- Recent Developments
7.1 Mar 13, 2024: Conformal Medical's CLAAS System Demonstrates Low Thrombogenicity Compared to Commercially Available LAAO Devices
7.2 Feb 06, 2024: The CLAAS System by Conformal Medical Demonstrates Sizing Simplicity and Seal Efficiency During AF Symposium Live Case Presentation
7.3 Feb 02, 2024: MicroPort CardioFlow Receives Approval for Its AnchorMan LAAC System in China
7.4 Nov 13, 2023: Jenscare : Simulock Successfully Completes Implantation Surgery for the First Confirmatory Clinical Trial
7.5 Oct 24, 2023: Conformal Medical Announces Compelling One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study
7.6 Oct 24, 2023: Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR
7.7 Sep 07, 2023: Boston Scientific’s LAAC device gets FDA approval
7.8 Sep 06, 2023: Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Left Atrial Appendage Closure Devices - Pipeline Products by Stage of Development
Table 2: Left Atrial Appendage Closure Devices - Pipeline Products by Territory
Table 3: Left Atrial Appendage Closure Devices - Pipeline Products by Regulatory Path
Table 4: Left Atrial Appendage Closure Devices - Pipeline Products by Estimated Approval Date
Table 5: Left Atrial Appendage Closure Devices - Ongoing Clinical Trials
Table 6: Left Atrial Appendage Closure Devices Companies - Pipeline Products by Stage of Development
Table 7: Left Atrial Appendage Closure Devices – Companies Pipeline Products by Stage of Development
Table 8: Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AMJ-505 Left Atrial Appendage Occlusion System - Product Status
Table 10: AMJ-505 Left Atrial Appendage Occlusion System - Product Description
Table 11: Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Aegis Sierra Ligation System - Product Status
Table 13: Aegis Sierra Ligation System - Product Description
Table 14: Append Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Appligator - Product Status
Table 16: Appligator - Product Description
Table 17: AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 18: F Aurigen Delivery System - Product Status
Table 19: F Aurigen Delivery System - Product Description
Table 20: Zenith LAA Occlusion System - Product Status
Table 21: Zenith LAA Occlusion System - Product Description
Table 22: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 23: AnchorMan Left Atrial Appendage Closure - Product Status
Table 24: AnchorMan Left Atrial Appendage Closure - Product Description
Table 25: WATCHMAN FLX Pro - Product Status
Table 26: WATCHMAN FLX Pro - Product Description
Table 27: Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: CLAAS Device - Product Status
Table 29: CLAAS Device - Product Description
Table 30: Conformal Medical Inc - Ongoing Clinical Trials Overview
Table 31: CLAAS Device - An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion
Table 32: CLAAS Device - The CONFORMAL Early Feasibility Study an Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 33: CLAAS Device - The Conformal Prague Study: An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 34: CLAAS Device - The Conscious Sedation Single Arm Sub-Study
Table 35: Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 36: StrokeShield System - Product Status
Table 37: StrokeShield System - Product Description
Table 38: Hangzhou Denuo Electrophysiology Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 39: E-SeaLA - Product Status
Table 40: E-SeaLA - Product Description
Table 41: Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Sensei Robotic Catheter System - LAA - Product Status
Table 43: Sensei Robotic Catheter System - LAA - Product Description
Table 44: Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 45: SimuLock - Product Status
Table 46: SimuLock - Product Description
Table 47: Johnson & Johnson Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Laminar Left Atrial Appendage Closure System - Product Status
Table 49: Laminar Left Atrial Appendage Closure System - Product Description
Table 50: Johnson & Johnson - Ongoing Clinical Trials Overview
Table 51: Laminar Left Atrial Appendage Closure System - A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects with Non- Valvular Atrial Fibrillation
Table 52: Laminar Left Atrial Appendage Closure System - An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects with Non-Valvular Atrial Fibrillation
Table 53: Laminar Left Atrial Appendage Closure System - Laminar Left Atrial Appendage Elimination (LAAX) Pivotal IDE Study
Table 54: Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 55: LAA Closure Occluder II - Product Status
Table 56: LAA Closure Occluder II - Product Description
Table 57: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 58: LAmbre LAA Closure System - Product Status
Table 59: LAmbre LAA Closure System - Product Description
Table 60: Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
Table 61: LAmbre LAA Closure System - Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF: The CORRAL-AF Study
Table 62: LAmbre LAA Closure System - LAmbre Versus AMPLATZER Amulet Left Atrial Appendage Occluder for Stroke Prophylaxis: The Randomized AMPIRI Trial
Table 63: LAmbre LAA Closure System - LifeTech LAmbre Keft Atrial Appendage (LAA) Closure System Post-market Clinical Follow-up
Table 64: LAmbre LAA Closure System - Lifetech LAmbre Left Atrial Appendage Closure System Post-Market Clinical Follow-up Multi-center, Single-arm, Prospective, Post-market study
Table 65: LAmbre LAA Closure System - Lifetech Lambre Left Atrial Appendage Closure System Post-market Registry Single-center, Single-arm, Prospective, Post-market Registry
Table 66: LAmbre LAA Closure System - Safety and Efficacy Study of LAmbre Plus LAA occluder System in Non-valvular Atrial Fibrillation Patients
Table 67: LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview
Table 68: LuSeed Intrasaccular Device - LAA Occlusion - Product Status
Table 69: LuSeed Intrasaccular Device - LAA Occlusion - Product Description
Table 70: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Left Atrial Appendage Closure Device - Product Status
Table 72: Left Atrial Appendage Closure Device - Product Description
Table 73: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Cardioblate Closure LAA Occlusion Device - Product Status
Table 75: Cardioblate Closure LAA Occlusion Device - Product Description
Table 76: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Left Atrial Appendage Occluder - Product Status
Table 78: Left Atrial Appendage Occluder - Product Description
Table 79: SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Eclipse Surgical Left Atrial Appendage Closure Device - Product Status
Table 81: Eclipse Surgical Left Atrial Appendage Closure Device - Product Description
Table 82: LARIAT Suture Delivery Device - Adjunctive Therapy - Product Status
Table 83: LARIAT Suture Delivery Device - Adjunctive Therapy - Product Description
Table 84: Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Left Atrial Appendage Occluder System - Product Status
Table 86: Left Atrial Appendage Occluder System - Product Description
Table 87: The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Status
Table 89: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Description
Table 90: Glossary
2.2 List of Figures
Figure 1: Left Atrial Appendage Closure Devices - Pipeline Products by Stage of Development
Figure 2: Left Atrial Appendage Closure Devices - Pipeline Products by Territory
Figure 3: Left Atrial Appendage Closure Devices - Pipeline Products by Regulatory Path
Figure 4: Left Atrial Appendage Closure Devices - Pipeline Products by Estimated Approval Date
Figure 5: Left Atrial Appendage Closure Devices - Ongoing Clinical Trials

$2,500
$5,000
$7,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings